Try a new search

Format these results:

Searched for:

person:hinesg02

in-biosketch:true

Total Results:

100


Frank J. Veith, MD: Vascular Surgeon, Pioneer, Leader

Fountain, Samantha; Hines, George; Wain, Reese
PMID: 39899511
ISSN: 1538-4683
CID: 5783742

Roy K. Greenberg and His Work on Endovascular Aortic Aneurysm Repair

Tan, Sally; Hines, George L
PMID: 39898645
ISSN: 1538-4683
CID: 5783702

Robert Gross MD and the Birth of Pediatric Heart Surgery

Krell, Matthew; Hines, George L
Robert Gross performed the first repair of a patent ductus arteriosus in 1938. His life and career were dedicated to the advancement of vascular, cardiac, pediatric surgery, and the unrelenting care of his patients.
PMID: 38833498
ISSN: 1538-4683
CID: 5665192

Francis Moore a Surgeon-Scientist: Career in Retrospect

Cimaroli, Sawyer; Hines, George
PMID: 36883819
ISSN: 1538-4683
CID: 5432742

Therapeutic Angiogenesis and Cardiovascular Disease: A Review

Ye, Ivan B; Hines, George L
After the success of novel angiogenesis inhibitors in cancer treatment, angiogenesis promotors for the treatment of peripheral vascular disease and coronary artery disease became the target of significant research. Promising results in animal models led to numerous randomized control trials that failed to translate into meaningful clinical results. The goal of this review is to describe the history of investigation into therapeutic angiogenesis for cardiovascular disease and discuss the lessons learned and future directions.
PMID: 38814076
ISSN: 1538-4683
CID: 5663742

The Evolution of Current Management for Carotid Artery Bifurcation Disease

Zohourian, Tirajeh; Hines, George
Options for treatment of symptomatic carotid bifurcation disease include carotid endarterectomy (CEA) and carotid artery stenting (CAS). While over the years CEA has established itself as the gold standard for carotid artery revascularization, results from recent trials have shown CAS to be safe and effective in selected patients. This review details the evolution of carotid artery bifurcation disease by highlighting key clinical trials.
PMID: 36729106
ISSN: 1538-4683
CID: 5420292

Marijuana and Vascular Disease: A Review

Ye, Ivan B; Hines, George L
Marijuana use is common and increasing due to decriminalization, legalization, and expansion of medical use. As a result, the proportion of vascular patients with marijuana is also expected to increase, raising questions if cannabis use affects the incidence and outcomes of vascular disease. Active ingredients of cannabis have been shown to interact with receptors found on vascular endothelium, promoting oxidative stress and endothelial dysfunction. However, current clinical studies have yet to demonstrate a relationship between marijuana use and atherosclerosis. Nonetheless, cannabis arteritis is a rare condition where cannabis is hypothesized to induce vascular inflammation. Future research with high-quality studies is needed to clarify the impact of marijuana use on vascular diseases.
PMID: 38189379
ISSN: 1538-4683
CID: 5755242

Vascular

Chapter by: Harris, Randi; Gooding, Rose C.; Llera, Brent; Hines, George; Wain, Reese
in: The ABSITE Blueprints by
[S.l.] : Springer International Publishing, 2023
pp. 495-528
ISBN: 9783031326424
CID: 5717752

Denton Cooley-Pioneer in the Development of Cardiovascular Surgery

Zohourian, Tirajeh; Hines, George
PMID: 36469358
ISSN: 1538-4683
CID: 5378592

Stents in the Management of Stenotic and Occlusive Lesions in the Venous System

Lee, Mary M; Hines, George L
Occlusive disease of the iliac veins or major intrathoracic veins have traditionally been managed by conservative management or by major vascular reconstructive procedures. Over the past 15-20 years, these lesions have become amenable to management with venous stents. Lesions in the iliac venous system are typically due to thrombus secondary to deep vein thrombosis, and lesions in the superior vena cava are due to either malignant intrathoracic lesions, indwelling central venous catheters, pacemaker leads, or enlarged nodes due to granulomatous disease. The success rate for implantation is between 92% and 95% and associated implantation complications vary between 2% and 5%. Primary patency of iliac stents is 70-90% at three years. Venous stents have higher patency in the treatment of stenotic lesions compared to totally occlusive lesions. Primary patency of stents placed in the superior vena cava is also about 70-90% and generally lower in lesions due to malignancy likely related to life expectancy. Stents in the venous system are associated with few complications at the time of insertion and have excellent long-term patency.
PMID: 36201242
ISSN: 1538-4683
CID: 5360722